GOSS W A, DEITZ W H, COOK T M
J Bacteriol. 1965 Apr;89(4):1068-74. doi: 10.1128/jb.89.4.1068-1074.1965.
Goss, William A. (Sterling-Winthrop Research Institute, Rensselaer, N.Y.), William H. Deitz, and Thomas M. Cook. Mechanism of action of nalidixic acid on Escherichia coli. II. Inhibition of deoxyribonucleic acid synthesis. J. Bacteriol. 89:1068-1074. 1965.-Nalidixic acid was shown to inhibit specifically the synthesis of deoxyribonucleic acid (DNA) in Escherichia coli. Slight effects on protein and ribonucleic acid (RNA) synthesis were observed only at higher levels of drug or after prolonged incubation. The inhibition of DNA synthesis in E. coli 15TAU, as measured by incorporation of C(14)-labeled thymine, was observed after exposure to nalidixic acid for 10 min. Inhibition of the incorporation of C(14)-labeled uracil into RNA and C(14)-labeled l-arginine into protein (21 and 28% inhibition, respectively) was observed only after 60 min of exposure. When cultures of E. coli 15TAU were exposed to 3.0 mug/ml of nalidixic acid (slightly greater than the minimal growth inhibitory concentration), the incorporation of C(14)-labeled thymidine was inhibited 30 to 40% after 90 min. Nalidixic acid at 10 mug/ml, a lethal concentration, inhibited thymidine incorporation 72% during this period. Nalidixic acid at 1.0 mug/ml had no apparent effect on the incorporation of C(14)-labeled adenine or C(14)-labeled uracil into RNA of cultures of E. coli 198, a wild-type strain. However, incorporation of both bases into DNA was strongly inhibited after 60 min of exposure (66 and 69%, respectively). Nalidixic acid inhibited DNA replication during a single round of synthesis. In contrast with "thymineless death," nalidixic acid was not lethal to E. coli 15TAU during restricted RNA and protein synthesis (i.e., in a medium containing thymine but lacking arginine and uracil). We have shown also that this chemotherapeutic agent has little effect on the synthesis of protein or RNA required to initiate DNA replication. After 75 min of inhibition, the capacity of E. coli 15TAU to synthesize DNA in a medium containing thymine, arginine, and uracil may be restored by a simple filtration and washing process, indicating that the drug is not firmly bound. These studies leave little doubt that a primary action of nalidixic acid is the inhibition of the synthesis of DNA in E. coli.
戈斯,威廉·A.(纽约州伦塞勒斯特林-温思罗普研究所),威廉·H. 戴茨,托马斯·M. 库克。萘啶酸对大肠杆菌的作用机制。II. 对脱氧核糖核酸合成的抑制。《细菌学杂志》89:1068 - 1074。1965年。已证明萘啶酸能特异性抑制大肠杆菌中脱氧核糖核酸(DNA)的合成。仅在较高药物浓度或长时间孵育后,才观察到对蛋白质和核糖核酸(RNA)合成有轻微影响。用C(14)标记的胸腺嘧啶掺入量来测定,暴露于萘啶酸10分钟后,观察到大肠杆菌15TAU中DNA合成受到抑制。仅在暴露60分钟后,才观察到C(14)标记的尿嘧啶掺入RNA以及C(14)标记的L - 精氨酸掺入蛋白质受到抑制(分别抑制21%和28%)。当大肠杆菌15TAU培养物暴露于3.0微克/毫升的萘啶酸(略高于最小生长抑制浓度)时,90分钟后C(14)标记的胸苷掺入受到30%至40%的抑制。10微克/毫升的萘啶酸,即致死浓度,在此期间抑制胸苷掺入72%。1.0微克/毫升的萘啶酸对野生型菌株大肠杆菌198培养物中C(14)标记的腺嘌呤或C(14)标记的尿嘧啶掺入RNA没有明显影响。然而,暴露60分钟后,两种碱基掺入DNA均受到强烈抑制(分别为66%和69%)。萘啶酸在一轮合成过程中抑制DNA复制。与“胸腺嘧啶饥饿死亡”不同,在受限的RNA和蛋白质合成过程中(即在含有胸腺嘧啶但缺乏精氨酸和尿嘧啶的培养基中),萘啶酸对大肠杆菌15TAU并不致命。我们还表明,这种化疗药物对启动DNA复制所需的蛋白质或RNA合成影响很小。抑制75分钟后,通过简单的过滤和洗涤过程,大肠杆菌15TAU在含有胸腺嘧啶、精氨酸和尿嘧啶的培养基中合成DNA的能力可以恢复,这表明药物没有牢固结合。这些研究毫无疑问地表明,萘啶酸的主要作用是抑制大肠杆菌中DNA的合成。